AzTrials
AzTrials

VapingEPIC/ADVANCENCT06919276

Nicotine and Cannabis Vape Labeling Experiment - Spring 2025

A study testing Vaping Device Labeling in people with Vaping and Adolescent, run by University of Southern California at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study assesses how the ways in which nicotine and cannabis vaping devices are labeled impact use susceptibility, anticipated effects, and health harm. Read more about this study

Who is it for?
Ages 11 to 19 yearsHealthy volunteers can take part
Conditions the study is for
Vaping, Adolescent, Electronic Cigarette Use
What is being tested?
Vaping Device Labeling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,048 participants
Where
1 siteUnited States
Study dates
3 Mar 2025to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 19 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Participants must be enrolled in a partnering high school.

Who cannot join

  • Participants who cannot independently understand study consent and the study surveys are ineligible.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Southern California

    Los Angeles, California, 90032

Other trials in United States

About this study

Official title: Longitudinal Patterns of Non-Combustible Tobacco Product Use in Adolescents (EPIC) / Assessing Development Patterns of Vaping, Alcohol, Nicotine, and Cannabis Use and Emotional Well-being (ADVANCE)

This study assesses how the ways in which nicotine and cannabis vaping devices are labeled impact use susceptibility, anticipated effects, and health harm.

Read the detailed description

The primary objectives of the study: (1) Determine whether different device labels with the contained substance (nicotine or cannabis) affect adolescent use susceptibility, anticipated effects or impairment, and perceived health harms; (2) Determine whether device color/product flavor differentially impact the study outcomes.

Being tested
Vaping Device Labeling
Keywords
vaping device, product labeling, use susceptibility, perceived harm, nicotine, cannabis
Medical subject headings
Vaping, Marijuana Abuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vaping Device LabelingOther

    Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented.

    The label conditions are:

    1. plain (i.e., no labeling on device)
    2. "contains THC"
    3. "contains 80% THC"
    4. "contains 80% THC - HIGH POTENCY"
    5. "contains nicotine"
    6. "contains 5% nicotine"
    7. "contains 5% nicotine - HIGH STRENGTH" The color/flavor conditions are: mint/mint, white/original, blue/blueberry.
Study groups in NCT06919276
Study groupRoleWhat they receive
Mint - Labeling Condition 1ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 1.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 2ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 2.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 3ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 3.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 4ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 4.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 5ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 5.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 6ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 6.
Receives: Other: Vaping Device Labeling
Mint - Labeling Condition 7ExperimentalParticipants will view an image of a mint-colored and flavored vape with label condition 7.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 1ExperimentalParticipants will view an image of a white colored and original vape with label condition 1.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 2ExperimentalParticipants will view an image of a white colored and original vape with label condition 2.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 3ExperimentalParticipants will view an image of a white colored and original vape with label condition 3.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 4ExperimentalParticipants will view an image of a white colored and original vape with label condition 4.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 5ExperimentalParticipants will view an image of a white colored and original vape with label condition 5.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 6ExperimentalParticipants will view an image of a white colored and original vape with label condition 6.
Receives: Other: Vaping Device Labeling
Original - Labeling Condition 7ExperimentalParticipants will view an image of a white colored and original vape with label condition 7.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 1ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 1.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 2ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 2.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 3ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 3.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 4ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 4.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 5ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 5.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 6ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 6.
Receives: Other: Vaping Device Labeling
Blueberry - Labeling Condition 7ExperimentalParticipants will view an image of a blue-colored and blueberry flavored vape with label condition 1.
Receives: Other: Vaping Device Labeling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Use Intention Susceptibility

    This 3-item self-report measure assesses participant interest in trying the vaping device in the future. A 4-level Likert scale is used: definitely not, probably not, probably yes, definitely yes.

    Measured: 5 minutes

  2. Perceived Health Harms

    This 2-item self-report measure assesses participant perception of health harms and risks associated with using the vaping product. A 4-level Likert scale is used: definitely not, probably not, probably yes, definitely yes.

    Measured: 5 minutes

  3. Anticipated Subjective Effects

    This 9-item self-report measure assesses anticipated subjective effects from using the vaping device. Participants will select all that apply.

    Measured: 5 minutes

  4. Anticipated Impairment/Enhancement

    This 4-item self-report measure assesses participant anticipated enhancement or impairment effects on completing different activities due to using the vaping product. A 5-level Likert scale is used: definitely make it harder, probably make it harder, no effect, probably make it easier, definitely make it easier.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2025
  2. Study start3 Mar 2025
  3. Primary completion1 May 2025
  4. Study completion1 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomized to one of seven labeling conditions and one of three device colors/flavors.
Masking
Single blind
Who is masked
Participant
Enrolment
3,048 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06919276
Sponsor's protocol ID
UP-23-00483/HS-19-00682
Other IDs
5K24DA048160, 5U54CA180905-12, 5R01CA229617-06
Acronym
EPIC/ADVANCE
Status last verified
May 2026
First submitted
28 Feb 2025
Last updated
22 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Vaping Device Labeling in people with Vaping and Adolescent, run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Use Intention Susceptibility (time frame: 5 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in